InsidersTradesSigma
Follow the 瑞普生物 share price and the full insider trade history of the company, a publicly traded company based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 瑞普生物 has published 2 public disclosures. Market capitalisation: €8.5bn. The latest transaction was disclosed on 16 June 2026 (Purchase). Among the most active insiders: 徐雷. The full history is free.
Analysts rate 瑞普生物 Buy (bullish), based on 3 analysts. Average price target: CN¥20.41.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
瑞普生物 es una empresa centrada en el sector de la salud y farmacéutico, especializada en la investigación y el desarrollo de soluciones biofarmacéuticas. Cotiza en el mercado XSHE.